- Home
- INO vs WEA Comparison
INO vs WEA Comparison
Compare INO & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INO | WEA |
|---|---|---|
| Founded | 1979 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.9M | 130.2M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | INO | WEA |
|---|---|---|
| Price | $1.66 | $10.65 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 686.0K | 31.7K |
| Earning Date | 06-16-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.87% |
| EPS Growth | ★ 54.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,220,086.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23,060.18 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.37 | N/A |
| 52 Week Low | $1.30 | $10.16 |
| 52 Week High | $2.86 | $11.44 |
Technical Indicators
Market Signals| Indicator | INO | WEA |
|---|---|---|
| Relative Strength Index (RSI) | 44.82 | 25.48 |
| Support Level | $1.48 | $10.47 |
| Resistance Level | $1.78 | $10.87 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 1.32 | 5.62 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.